Endocrinology Practice Questions

Q: A patient admitted to the Intensive Care Unit following a head injury presented with signs of raised intracranial pressure. The patient was ventilated and managed with intravenous fluids and diuretics. Twenty-four hours later, the patient's urine output was 3.5 liters, serum sodium was 156 mEq/L, and serum osmolality was 316 mOsm/kg. Based on these parameters, what is the most likely diagnosis?

High urine output due to diuretics. The patient presents with polyuria (3.5 L/day), hypernatremia (156 mEq/L), and high serum osmolality (316 mOsm/kg) following management for raised intracranial pressure (ICP). **Why Option A is correct:** In the management of raised ICP, osmotic diuretics like **Mannitol** are the gold standard. Mannitol works by creating an osmotic gradient that draws fluid from the brain parenchyma into the intravascular space, which is then excreted by the kidneys. This leads to an **osmotic diuresis**, resulting in high urine output and a relative loss of free water, which explains the elevated serum sodium and osmolality [1]. **Why the other options are incorrect:** * **B. Diabetes Insipidus (DI):** While DI (Central or Nephrogenic) causes polyuria and hypernatremia, it typically presents with **low urine osmolality** (dilute urine). In the context of ICU management for head injury, diuretic use is a more immediate pharmacological cause for these lab values. * **C. Excessive Normal Saline:** While this could cause hypernatremia, it would not typically result in significant polyuria unless the kidneys are compensating perfectly; furthermore, it doesn't align with the specific management protocol for raised ICP. * **D. Cerebral Salt-Wasting (CSW):** CSW presents with polyuria but is characterized by **hyponatremia** and volume depletion due to excessive renal sodium excretion, which contradicts this patient’s hypernatremic state. **Clinical Pearls for NEET-PG:** * **Mannitol Side Effects:** Initial volume expansion (risk of pulmonary edema) followed by osmotic diuresis leading to dehydration and hypernatremia [1]. * **DI vs. CSW vs. SIADH:** * **DI:** High Na+, High Osmolality, Low Urine Osmolality. * **CSW:** Low Na+, High Urine Na+, Hypovolemia. * **SIADH:** Low Na+, High Urine Osmolality, Euvolemia. * Always check the **medication history** in ICU scenarios before diagnosing primary endocrine disorders.

Q: All are true about central hypothyroidism except?

Treatment is guided by TSH levels in plasma. **Explanation:** Central hypothyroidism (secondary/tertiary) occurs due to pathology in the pituitary gland or hypothalamus, leading to insufficient TSH production or activity [3]. **1. Why Option B is the Correct Answer (The False Statement):** In central hypothyroidism, the TSH level is unreliable because the pituitary is the source of the pathology. TSH may be low, inappropriately "normal," or even slightly elevated (due to biologically inactive TSH) [2]. Therefore, **treatment is guided by Free T4 (FT4) levels**, aiming for the upper half of the reference range [2]. Using TSH to monitor therapy would lead to under-treatment. **2. Analysis of Other Options:** * **Option A (Craniopharyngioma):** This is the most common tumor causing central hypothyroidism in children and young adults by compressing the hypothalamus or pituitary stalk. * **Option C (TSH not a good marker for diagnosis):** Correct. Diagnosis relies on finding a **low Free T4** in the presence of a TSH that is not appropriately elevated (low or normal). * **Option D (Check for adrenal insufficiency):** Crucial clinical step. Central hypothyroidism often coexists with ACTH deficiency. Starting Levothyroxine before Glucocorticoids can precipitate an **acute adrenal crisis** by increasing the metabolic clearance of the little cortisol remaining [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of Thumb:** In Primary Hypothyroidism, follow TSH. In Central Hypothyroidism, follow Free T4 [2]. * **The "Pituitary-Adrenal" Rule:** Always rule out or treat adrenal insufficiency *before* thyroid replacement in any patient with suspected pituitary disease [2]. * **Common Causes:** Pituitary adenomas (most common in adults), Sheehan syndrome, trauma, and surgery/radiation [1].

Q: All of the following are features of MEN IIa, except?

Pituitary tumor. **Explanation:** The **Multiple Endocrine Neoplasia (MEN)** syndromes are autosomal dominant conditions caused by germline mutations. This question tests the ability to differentiate between MEN I and MEN IIa. **1. Why Pituitary Tumor is the Correct Answer:** Pituitary tumors are a hallmark of **MEN I (Wermer’s Syndrome)**, not MEN IIa. MEN I is characterized by the "3 Ps": **P**ituitary adenomas, **P**arathyroid hyperplasia, and **P**ancreatic islet cell tumors. Therefore, its presence in a list describing MEN IIa makes it the "except" option. **2. Analysis of Incorrect Options (Features of MEN IIa):** MEN IIa (Sipple Syndrome) is caused by a mutation in the **RET proto-oncogene** and typically presents with: * **Medullary Carcinoma Thyroid (MTC):** Occurs in nearly 100% of cases; often the first manifestation. * **Pheochromocytoma:** Occurs in approximately 50% of patients; often bilateral. * **Parathyroid Hyperplasia:** Seen in about 20-30% of cases, leading to hypercalcemia. **Clinical Pearls for NEET-PG:** * **MEN IIa vs. IIb:** Both feature MTC and Pheochromocytoma. However, MEN IIa includes Parathyroid hyperplasia, while **MEN IIb** features Mucosal neuromas, Marfanoid habitus, and Intestinal ganglioneuromatosis (but *no* parathyroid involvement). * **Screening:** For MEN II syndromes, screening for the **RET mutation** is the gold standard. Prophylactic thyroidectomy is often indicated in mutation carriers. * **Rule of Thumb:** If you see "Pituitary" or "Pancreas," think MEN I. If you see "Medullary Thyroid CA," think MEN II.

Q: Paroxysmal hypotension is seen in which of the following conditions?

Carcinoid syndrome. **Explanation:** **Carcinoid syndrome** is the correct answer because it is characterized by the systemic release of vasoactive substances, primarily **serotonin, bradykinins, and histamine**, from neuroendocrine tumors (usually after metastasizing to the liver) [1]. While serotonin typically causes vasoconstriction, the release of **bradykinins and prostaglandins** leads to profound peripheral vasodilation. This results in the classic clinical triad of cutaneous flushing, diarrhea, and **paroxysmal hypotension** [1]. In some cases, severe episodes can lead to a "carcinoid crisis," a life-threatening state of profound hypotension. **Why the other options are incorrect:** * **Lymphoma & Leukemia:** These hematological malignancies typically present with constitutional symptoms (B-symptoms) like fever, night sweats, and weight loss. While they can cause hypotension in the context of sepsis or superior vena cava syndrome, they do not cause paroxysmal episodes mediated by vasoactive amines. * **Infectious Mononucleosis:** Caused by the Epstein-Barr virus (EBV), this presents with the triad of fever, pharyngitis, and lymphadenopathy. Hypotension is not a characteristic feature unless complicated by splenic rupture or rare secondary infections. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** The best initial screening test is **24-hour urinary 5-HIAA** (a metabolite of serotonin). * **Localization:** Somatostatin receptor scintigraphy (**OctreoScan**) is the gold standard for locating the primary tumor. * **Management:** **Octreotide** (a somatostatin analog) is the drug of choice to manage symptoms and prevent carcinoid crisis during surgery. * **Cardiac Involvement:** Look for **Hedinger syndrome** (fibrosis of the right-sided heart valves, specifically tricuspid regurgitation and pulmonary stenosis).

Q: All are clinical features of pheochromocytoma, except?

Low cortisol level. **Explanation:** Pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla [1]. The clinical features are primarily driven by the excessive release of epinephrine and norepinephrine [2]. **Why "Low cortisol level" is the correct answer:** Pheochromocytoma does not cause low cortisol levels. In fact, chronic stress from catecholamine excess can sometimes lead to **elevated** cortisol levels due to ACTH stimulation. Furthermore, some pheochromocytomas can ectopically secrete ACTH, leading to Cushing’s syndrome. Therefore, low cortisol is not a feature of this condition. **Analysis of incorrect options:** * **Increased hematocrit:** Catecholamines cause a contraction of the plasma volume (due to vasoconstriction). This leads to **relative polycythemia** (spurious erythrocytosis), resulting in an elevated hematocrit. * **Orthostatic hypotension:** Despite being a hypertensive state, patients often experience orthostatic hypotension. This occurs due to a combination of **low plasma volume** and impaired sympathetic reflex mechanisms (downregulation of alpha-receptors) caused by chronic catecholamine exposure. * **Impaired glucose tolerance:** Catecholamines inhibit insulin secretion (via alpha-2 receptors) and stimulate glycogenolysis and gluconeogenesis [2]. This leads to **hyperglycemia** and glucose intolerance in about 50% of patients. **High-Yield Clinical Pearls for NEET-PG:** * **The Rule of 10s:** 10% bilateral, 10% malignant, 10% pediatric, 10% extra-adrenal (Paraganglioma). * **Classic Triad:** Episodic headache, sweating (diaphoresis), and palpitations. * **Diagnosis:** Best initial screening test is **24-hour urinary fractionated metanephrines** or plasma free metanephrines. * **Management:** Always give **Alpha-blockers first** (e.g., Phenoxybenzamine) before Beta-blockers to avoid a hypertensive crisis from unopposed alpha-stimulation.

Q: Which lipid abnormality is most commonly associated with diabetes mellitus?

Triglycerides. **Explanation:** The characteristic pattern of dyslipidemia in Diabetes Mellitus (often termed **Diabetic Dyslipidemia**) is primarily driven by insulin resistance. In the state of insulin deficiency or resistance, there is increased lipolysis in adipose tissue, leading to an influx of free fatty acids into the liver [1]. This stimulates the overproduction of **Very Low-Density Lipoprotein (VLDL)**, which is rich in **Triglycerides** [3]. Consequently, hypertriglyceridemia is the most common and hallmark lipid abnormality in diabetic patients. **Analysis of Options:** * **Triglycerides (Correct):** Elevated levels occur due to increased hepatic VLDL synthesis and decreased clearance by lipoprotein lipase (LPL), which is insulin-dependent [3]. * **High-density lipoprotein (HDL):** While low HDL is a classic feature of diabetic dyslipidemia, it is a secondary consequence. High triglycerides lead to an exchange where HDL loses protein and gains triglycerides, making it smaller and more easily cleared by the kidneys [2]. Thus, HDL is typically *low*, not high. * **Cholesterol:** Total cholesterol or LDL-C levels may not be significantly higher in diabetics compared to non-diabetics. However, the *quality* of LDL changes; it becomes "Small Dense LDL" (Pattern B), which is highly atherogenic [2]. **NEET-PG High-Yield Pearls:** * **The Lipid Triad of Diabetes:** 1. Hypertriglyceridemia, 2. Low HDL, 3. Small dense LDL particles [2]. * **Target:** In diabetic patients, the primary target of therapy remains **LDL-C** (to reduce CV risk), but the most common baseline abnormality is **Triglycerides**. * **Drug of Choice:** Statins are the first-line treatment for diabetic dyslipidemia to reduce cardiovascular events, regardless of the baseline lipid profile.

Q: A 52-year-old woman presents with a 1-year history of upper truncal obesity and moderate depression. Physical examination shows hirsutism and moon facies. A CT scan of the thorax displays a hilar mass. A transbronchial lung biopsy discloses small cell carcinoma. Electron microscopy of this patient's lung tumor will most likely reveal which of the following cytologic features?

Neuroendocrine granules. ### Explanation **Clinical Correlation:** The patient presents with classic features of **Cushing Syndrome** (truncal obesity, moon facies, hirsutism, and depression) secondary to **Ectopic ACTH secretion**. The presence of a hilar mass diagnosed as **Small Cell Lung Carcinoma (SCLC)** confirms the source. SCLC is a neuroendocrine tumor known for paraneoplastic syndromes, most commonly SIADH and ectopic ACTH production [1]. **Why the Correct Answer is Right:** Small cell lung carcinoma is derived from **Kulchitsky cells** (enterochromaffin cells), which are part of the APUD (Amine Precursor Uptake and Decarboxylation) system. Under electron microscopy, these neuroendocrine cells characteristically contain **membrane-bound, electron-dense neurosecretory granules**. These granules store the hormones (like ACTH) that lead to the patient's clinical presentation. **Analysis of Incorrect Options:** * **A. Councilman bodies:** These are eosinophilic, apoptotic hepatocytes typically seen in viral hepatitis (especially Yellow Fever). * **B. Hyperplasia of endoplasmic reticulum:** While the Smooth ER is involved in steroid synthesis (seen in the adrenal cortex), it is not a diagnostic feature of the lung tumor itself. * **C. Mitochondrial calcification:** This is a sign of irreversible cell injury/necrosis, not a specific feature of neuroendocrine tumors. **NEET-PG High-Yield Pearls:** * **SCLC Markers:** Positive for Chromogranin A, Synaptophysin, and CD56. * **Paraneoplastic Syndromes of SCLC:** SIADH (most common), Ectopic ACTH (Cushing’s), and Lambert-Eaton Myasthenic Syndrome [2]. * **Azzopardi Effect:** A characteristic histological finding in SCLC where DNA from necrotic tumor cells encrusts vessel walls. * **Treatment:** SCLC is usually disseminated at the time of diagnosis; therefore, chemotherapy is the mainstay of treatment rather than surgery.

Q: For FITTER, what is the shortest needle length in mm that should be used?

4. The **FITTER (Forum for Injection Technique and Therapy Expert Recommendations)** guidelines emphasize that the primary goal of insulin injection is to deliver the drug into the **subcutaneous (SC) space** while avoiding accidental **intramuscular (IM)** injection. **1. Why 4 mm is the correct answer:** The human skin (epidermis and dermis) thickness at injection sites rarely exceeds 2.5 mm, regardless of BMI, age, or ethnicity. A **4 mm needle** is the shortest available length and is considered the **gold standard** for all patients (including obese individuals). It is long enough to pass through the skin into the SC tissue but short enough to significantly reduce the risk of painful IM injections, which can cause unpredictable glucose fluctuations and hypoglycemia. **2. Why the other options are incorrect:** * **5 mm & 6 mm:** While these were previously common, they increase the risk of IM injection, especially in children, thin adults, or when injecting into the limbs. * **8 mm:** This length is now largely discouraged for routine insulin therapy. Using an 8 mm needle often requires a skin fold (pinch-up) technique to avoid the muscle, increasing the complexity of the injection and the risk of needle-stick injuries. **High-Yield Clinical Pearls for NEET-PG:** * **Site Rotation:** Essential to prevent **Lipohypertrophy**, which can delay insulin absorption. * **No Pinch Technique:** With a 4 mm needle, a 90-degree insertion without a skin fold is recommended for most adults. * **IM Injection Risk:** Insulin absorbed from muscle acts much faster than SC insulin, leading to severe, unexplained hypoglycemia. * **Single Use:** Needles should not be reused as it causes microscopic "barbing," leading to tissue trauma and lipohypertrophy.

Q: Which of the following is NOT a feature of primary hyperaldosteronism?

Pedal edema. Primary hyperaldosteronism (Conn’s syndrome) is characterized by the autonomous overproduction of aldosterone, leading to sodium retention and potassium excretion [1]. **Why Pedal Edema is NOT a feature (The "Aldosterone Escape" Phenomenon):** Despite significant sodium and water retention, patients with primary hyperaldosteronism **do not** typically develop pedal edema. This is due to the **"Aldosterone Escape"** mechanism [1]. As intravascular volume expands, the body compensates by increasing the secretion of **Atrial Natriuretic Peptide (ANP)** and increasing the pressure natriuresis in the kidneys. This results in the excretion of excess sodium and water, preventing the formation of overt edema and limiting the severity of hypernatremia [1]. **Analysis of Incorrect Options:** * **Diastolic Hypertension:** Aldosterone increases sodium reabsorption in the distal tubules, leading to volume expansion and increased peripheral resistance, which characteristically raises diastolic blood pressure. * **Polyuria:** Chronic hypokalemia causes **nephrogenic diabetes insipidus** (resistance to ADH), leading to the inability to concentrate urine, resulting in polyuria and nocturia. * **Hypokalemia:** Aldosterone promotes potassium secretion in the cortical collecting duct [1]. While 20-40% of patients may be normokalemic, hypokalemia remains a classic hallmark, often exacerbated by thiazide diuretics [1]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Screening Test:** Plasma Aldosterone Concentration (PAC) to Plasma Renin Activity (PRA) ratio. A **PAC:PRA ratio > 20-30** is highly suggestive. 2. **Confirmatory Test:** Saline infusion test or Oral salt loading test. 3. **Metabolic State:** Patients typically exhibit **Hypokalemic Metabolic Alkalosis** [1]. 4. **Treatment:** Surgical excision for unilateral adenoma; **Spironolactone** or Eplerenone (Aldosterone antagonists) for bilateral adrenal hyperplasia.

Question 1

A patient admitted to the Intensive Care Unit following a head injury presented with signs of raised intracranial pressure. The patient was ventilated and managed with intravenous fluids and diuretics. Twenty-four hours later, the patient's urine output was 3.5 liters, serum sodium was 156 mEq/L, and serum osmolality was 316 mOsm/kg. Based on these parameters, what is the most likely diagnosis?

Accepted Answer

High urine output due to diuretics

Answer

Diabetes insipidus

Answer

Excessive infusion of normal saline

Answer

Cerebral salt-wasting syndrome

Question 2

All are true about central hypothyroidism except?

Accepted Answer

Treatment is guided by TSH levels in plasma

Answer

Craniopharyngioma

Answer

TSH level is not a good marker for diagnosis

Answer

Before starting treatment, check for adrenal insufficiency

Question 3

All of the following are features of MEN IIa, except?

Accepted Answer

Pituitary tumor

Answer

Pheochromocytoma

Answer

Medullary carcinoma thyroid

Answer

Parathyroid hyperplasia

Question 4

Paroxysmal hypotension is seen in which of the following conditions?

Accepted Answer

Carcinoid syndrome

Answer

Lymphoma

Answer

Leukemia

Answer

Infectious mononucleosis

Question 5

All are clinical features of pheochromocytoma, except?

Accepted Answer

Low cortisol level

Answer

Increased hematocrit

Answer

Orthostatic hypotension

Answer

Impaired glucose tolerance

Question 6

Which lipid abnormality is most commonly associated with diabetes mellitus?

Accepted Answer

Triglycerides

Answer

High-density lipoprotein (HDL)

Answer

Cholesterol

Question 7

A 52-year-old woman presents with a 1-year history of upper truncal obesity and moderate depression. Physical examination shows hirsutism and moon facies. A CT scan of the thorax displays a hilar mass. A transbronchial lung biopsy discloses small cell carcinoma. Electron microscopy of this patient's lung tumor will most likely reveal which of the following cytologic features?

Accepted Answer

Neuroendocrine granules

Answer

Councilman bodies

Answer

Hyperplasia of endoplasmic reticulum

Answer

Mitochondrial calcification

Question 8

In which of the following conditions is intensive management of diabetes mellitus NOT needed?

Accepted Answer

Diabetes mellitus with acute myocardial infarction

Answer

Autonomic neuropathy causing postural hypotension

Answer

Pregnancy

Answer

Post kidney transplant in a diabetic patient with nephropathy

Question 9

For FITTER, what is the shortest needle length in mm that should be used?

Accepted Answer

4

Answer

5

Answer

6

Answer

8

Question 10

Which of the following is NOT a feature of primary hyperaldosteronism?

Accepted Answer

Pedal edema

Answer

Diastolic hypertension

Answer

Polyuria

Answer

Hypokalemia

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?